BioSpace News Archive

Avivagen Inc. announces that it is accelerating its plans for commercial launch of its OxC-Beta product as a supplement for human use in response to the COVID-19 pandemic.

TransMedics Group, Inc. today announced that the Company and FDA/CDRH have mutually agreed to postpone the originally scheduled April 16 th FDA Advisory Committee meeting to review the OCS Heart System due to the national emergency status relating to the COVID-19 Cornavirus. Tran

Tris Pharma, Inc. (“Tris”), a specialty pharmaceutical company with a robust portfolio of approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, amidst the uncertainty created by the COVID-19 pandemic, reiterated its commitment to the ADHD community by assuring ADHD pat

Fourth-quarter GAAP earnings per share (EPS) were a loss of $0.05; adjusted EPS 1 totaled $0.97

Afya Limited, or Afya, in light of the recent developments of the Coronavirus pandemic, informs shareholders and the market of the measures the company is taking to mitigate any potential impact to students and employees.

HTG Molecular Diagnostics, Inc. announced that it will report its financial results for the year ended December 31, 2019 after the market close on Wednesday March 25, 2020.

Capricor Therapeutics today announced the expansion of its strategic plan to further develop the company’s exosome platform technologies. In conjunction with these efforts, Stephen Gould, Ph.D. has been appointed as Executive Consultant to gu

Tabula Rasa HealthCare and BioIntelliSense Partnership enables remote monitoring including symptoms of COVID-19

Thrive Earlier Detection Corp., today announced three key executive appointments: Matt Franklin has been appointed chief commercial officer; Sarah Larson, partner and chief human resources officer at Third Rock Ventures, has joined the company’s board of directors; and Semi Trotto has been promoted to

Nearly 2,700 Red Cross blood drives have been canceled across the country due to coronavirus concerns, resulting in some 86,000 fewer blood donations